ELACESTRANT in Women and Men with CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer: An Open-Label Multicenter Phase 2 Study (ELCIN)
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/cancer.jpg)
Details
Age
Adult
Locations
University of Colorado Hospital
Principal Investigator
![Photograph of Peter Kabos](https://som.ucdenver.edu/FIMS/Content/faculty/13514/CU-Doctors-13514.jpg)
Peter Kabos
Study ID
Protocol Number: 23-0641
More information available at ClinicalTrials.gov: NCT05596409
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers